The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments
about
Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signalingRetinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventionsSenescence from G2 arrest, revisitedRecent advances of highly selective CDK4/6 inhibitors in breast cancerDownregulation of P16 promotes cigarette smoke extract-induced vascular smooth muscle cell proliferation via preventing G1/S phase transitionIncreased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodesThe molecular balancing act of p16(INK4a) in cancer and aging.Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsCDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer.The history and future of targeting cyclin-dependent kinases in cancer therapy.Role of DNA methylation in cell cycle arrest induced by Cr (VI) in two cell lines.p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.Novel p16 binding peptide development for p16-overexpressing cancer cell detection using phage display.RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer.Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine.Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors.Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinomaTherapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors.Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer.A network of genes antagonistic to the LIN-35 retinoblastoma protein of Caenorhabditis elegans.p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition.Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique VulnerabilitiesHNdb: an integrated database of gene and protein information on head and neck squamous cell carcinoma.The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformationMitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1.Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision MedicineThe cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage.CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.A genotoxic stress-responsive miRNA, miR-574-3p, delays cell growth by suppressing the enhancer of rudimentary homolog gene in vitro.Effect of tumor suppressor gene cyclin-dependent kinase inhibitor 2A wild-type and A148T mutant on the cell cycle of human ovarian cancer cells.Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections.Signaling through cyclin D-dependent kinases.The role of epigenetics in the biology of multiple myeloma.Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Clinicopathological and immunohistological features of polypoid endometriosis.
P2860
Q24323184-A116B210-3CA6-48A1-B930-CC28C88D2EB2Q27022834-FD3F3EF0-58BD-417D-8E1B-926B6F9ACB09Q28088672-1E133E37-D84B-4E1D-B0CD-E369C487A0ACQ33602076-4DF7A1EE-BEF2-4CF2-98D7-62DD0114A43EQ33846805-44A66CD8-04E4-4F67-9A3E-311206590E4BQ33913936-7F645D7A-1762-41DE-8C54-42B54A79A79AQ34038585-6D5912D9-3DE7-4BB2-8138-435BCB48C01BQ34103945-214F73BC-F63F-4882-BC90-CF83ECA7CCFDQ34227791-BBAF0964-F014-4D55-9CD2-ADBECDBCA052Q34460347-5E291500-1915-43E5-A2E8-63930772270AQ34936658-58519D26-4B3B-41FC-929B-AE8C690730AAQ34988794-AD8B92F6-CF7D-4E67-AB07-22A8AFFBA5A9Q35152839-283AB25D-8C7A-437B-AE5C-C51FA1291A4AQ35574209-8B607D08-EAD8-4188-A8D2-452BDA001015Q35620241-F7A61761-59FD-4025-9DD2-08B65E35C4C6Q35757333-75D1A34D-9CA3-4F16-97CB-38DA01A6418DQ35758932-25159039-98E6-4D36-8186-B63FEDE139C9Q35863172-F0FCAB0F-5BB6-4961-813D-4F30900F20FBQ36103306-3A9C4603-D12A-431E-81AE-66C4D2D7954FQ36130090-7D5D72A7-CE13-4407-BFCF-55EF2FC5FA5DQ36140625-08862804-FECE-4938-9D24-0BA2C3B2D17DQ36154459-247C44C1-2523-4938-B604-B56FF4382E2FQ36520748-51BC245D-A1F8-49FD-84DD-1F92647F8CE6Q36590413-A8ADED39-E1B9-4B94-8CE7-9039886BF232Q36725425-55E077B2-A074-43D1-8871-9191CC90C79EQ36903218-E80D0F08-2AE3-4245-BD91-DC7609AE058FQ36921242-7EE3C381-4D43-40C0-9366-EA3CBC3F2E57Q36961667-8A39A37C-F279-40C2-A888-D60293F3372AQ37225495-C6A36348-3395-42E5-A63D-D9C04466497BQ37230991-F31AAC68-1E29-4B8D-9493-9E9B3E0F51ABQ37368732-F5135994-0814-4A90-9664-E16F3C96DDFFQ37420058-82B0EE42-2CE8-49D6-B7FF-4C4805126D13Q37481203-FF201711-FEFF-4F35-8A42-B99340EA621BQ37645370-83A43F3F-8178-4431-84F8-37476F5C24FAQ37652328-260ADD4F-7AFF-4096-97BA-2435B057356CQ37998530-4F185347-E3F0-4CBF-AB7C-F19CAED80270Q38104238-E4C280A1-6DEA-4D54-A7CB-A0112D857EBAQ38208520-0B83683D-8D7D-4407-AAD4-AC5AEC24121EQ38264616-4BB80557-D143-48F2-94E8-F67DACC3F8EDQ38533617-B8EA4CF0-5E01-4124-9FB1-77AF746E9131
P2860
The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The meaning of p16(ink4a) expr ...... ations and future developments
@ast
The meaning of p16(ink4a) expr ...... ations and future developments
@en
The meaning of p16(ink4a) expr ...... ations and future developments
@nl
type
label
The meaning of p16(ink4a) expr ...... ations and future developments
@ast
The meaning of p16(ink4a) expr ...... ations and future developments
@en
The meaning of p16(ink4a) expr ...... ations and future developments
@nl
prefLabel
The meaning of p16(ink4a) expr ...... ations and future developments
@ast
The meaning of p16(ink4a) expr ...... ations and future developments
@en
The meaning of p16(ink4a) expr ...... ations and future developments
@nl
P2860
P356
P1433
P1476
The meaning of p16(ink4a) expr ...... ations and future developments
@en
P2093
Agnieszka K Witkiewicz
Erik S Knudsen
P2860
P304
P356
10.4161/CC.10.15.16776
P577
2011-08-01T00:00:00Z